The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Xuan Liu, Jingning Luo, Jianwen Chen, Ping Huang, Gongyun He, Xueshi Ye, Ruiqi Su, Yaoqiang Lao, Yang Wang, Xiangjun He, Jingxia Zhang
Formato: Artículo Open Access
Publicado: Wiley 2024
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867002333110468608
author Xuan Liu
Jingning Luo
Jianwen Chen
Ping Huang
Gongyun He
Xueshi Ye
Ruiqi Su
Yaoqiang Lao
Yang Wang
Xiangjun He
Jingxia Zhang
author_facet Xuan Liu
Jingning Luo
Jianwen Chen
Ping Huang
Gongyun He
Xueshi Ye
Ruiqi Su
Yaoqiang Lao
Yang Wang
Xiangjun He
Jingxia Zhang
Xuan Liu
Jingning Luo
Jianwen Chen
Ping Huang
Gongyun He
Xueshi Ye
Ruiqi Su
Yaoqiang Lao
Yang Wang
Xiangjun He
Jingxia Zhang
collection Wiley Open Access
contents The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke Xuan Liu Jingning Luo Jianwen Chen Ping Huang Gongyun He Xueshi Ye Ruiqi Su Yaoqiang Lao Yang Wang Xiangjun He Jingxia Zhang CNS Neuroscience & Therapeutics ABSTRACTBackgroundThe oxidative stress and neuroinflammation are important factors in acute ischemic stroke (AIS). Our former study showed the 1,2,4‐ triazole derivative (SYS18) had obviously neuroprotection by anti‐ oxidative stress on rat middle cerebral artery occlusion (MCAO) model.AimIn this study, we continue to investigate its neuroprotection by anti‐inflammatory effects and protecting BBB integrity in AIS.Methods and ResultsFirst, its effect on acute inflammation was evaluated by the mice model of increased peritoneal capillary permeability. Then, the MCAO cerebral edema models were built to evaluate its neuroprotection by reducing the neurological score, cerebral edema, improving the biochemical indicators, and pathological damage of brain tissue. At the same time, its protection on blood–brain barrier (BBB) integrity was proved by decreasing the BBB permeability and inhibiting glycocalyx degradation and regulating the BBB tight junction proteins expression of matrix metalloproteinase‐ 9 (MMP‐ 9) and claudin‐ 5 in brain tissue. Meanwhile, pharmacokinetic experiments showed that the compound had good BBB penetration. It has some advantages in the intensity of efficacy compared with the marketed drug edaravone.ConclusionBased on these findings, SYS18 has a strong potential to become a neuroprotectant in the future. 10.1111/cns.70113 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/cns.70113
format Artículo Open Access
id wiley_oa_10_1111_cns_70113
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke
Xuan Liu
Jingning Luo
Jianwen Chen
Ping Huang
Gongyun He
Xueshi Ye
Ruiqi Su
Yaoqiang Lao
Yang Wang
Xiangjun He
Jingxia Zhang
CNS Neuroscience & Therapeutics
The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke Xuan Liu Jingning Luo Jianwen Chen Ping Huang Gongyun He Xueshi Ye Ruiqi Su Yaoqiang Lao Yang Wang Xiangjun He Jingxia Zhang CNS Neuroscience & Therapeutics ABSTRACTBackgroundThe oxidative stress and neuroinflammation are important factors in acute ischemic stroke (AIS). Our former study showed the 1,2,4‐ triazole derivative (SYS18) had obviously neuroprotection by anti‐ oxidative stress on rat middle cerebral artery occlusion (MCAO) model.AimIn this study, we continue to investigate its neuroprotection by anti‐inflammatory effects and protecting BBB integrity in AIS.Methods and ResultsFirst, its effect on acute inflammation was evaluated by the mice model of increased peritoneal capillary permeability. Then, the MCAO cerebral edema models were built to evaluate its neuroprotection by reducing the neurological score, cerebral edema, improving the biochemical indicators, and pathological damage of brain tissue. At the same time, its protection on blood–brain barrier (BBB) integrity was proved by decreasing the BBB permeability and inhibiting glycocalyx degradation and regulating the BBB tight junction proteins expression of matrix metalloproteinase‐ 9 (MMP‐ 9) and claudin‐ 5 in brain tissue. Meanwhile, pharmacokinetic experiments showed that the compound had good BBB penetration. It has some advantages in the intensity of efficacy compared with the marketed drug edaravone.ConclusionBased on these findings, SYS18 has a strong potential to become a neuroprotectant in the future. 10.1111/cns.70113 http://creativecommons.org/licenses/by/4.0/
title The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke
topic CNS Neuroscience & Therapeutics
url https://onlinelibrary.wiley.com/doi/10.1111/cns.70113